[1]李石.肝纤维化发生机制[J].中华消化杂志, 1999, 19 (1) ∶48-50.
|
[2]Bauer M, Schuppan D.TGF beta1 in liver fibrosis:time to changeparadigms?[J].FEBS Lett, 2001, 502 (1-2) ∶1-3.
|
[3] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[4]Bissell DM, Roulot D, George J, et al.Transforming growth factorβand liver[J].Hepatology, 2001, 34 (5) ∶859-867.
|
[5]Nagashio Y, Ueno H, Imamura M, et al.Inhibition of transforminggrowth factor beta decreases pancreatic fibrosis and protects the pan-creas against chronic injury in mice[J].Lab Invest, 2004, 84 (12) ∶1610-1618.
|
[6]卢平, 周力, 张永宏.转化生长因子β1-Smads信号传导与肝纤维化的关系[J].临床肝胆病杂志, 2006, 22 (1) ∶69-71.
|
[7]李兵顺, 阎文昭, 刘金星, 等.纤维化肝组织转化生长因子β1表达与肝纤维化程度的关系[J].中华传染病杂志, 2005, 23 (2) ∶112-114.
|
[8]张愚, 屈文东, 黄华, 等.bFGF及TGF-β1在实验性肝硬化中的免疫组化研究[J].胃肠病学和肝病学杂志, 2005, 14 (1) ∶40-44.
|
[1] | Nenghong YANG, Likun REN, She TIAN, Min HAN, Zhu LI, Yuxiang ZHAO, Peng LIU. Effect of laminin subunit α3 on epithelial-mesenchymal transition, invasion, and metastasis abilities of pancreatic cancer[J]. Journal of Clinical Hepatology, 2025, 41(2): 322-332. doi: 10.12449/JCH250219 |
[2] | Yan CHAI, Tao ZHANG, Yinke FAN, Aiwu HUI, Lintao ZHAO, Fang LI, Xiaoli ZHANG. Effect of Yangxue Rougan pills on the TGF-β1/Smad signaling pathway in a rat model of liver fibrosis induced by multiple factors[J]. Journal of Clinical Hepatology, 2022, 38(9): 2040-2045. doi: 10.3969/j.issn.1001-5256.2022.09.018 |
[3] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
[4] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
[5] | Feng Jie, Tang ZhengHao, Yu YongSheng. Expression of transcription factor Sp1 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(1): 65-67. |
[6] | Zheng SuJun, Xing XinYue, Wu JuShan, Wang ShiMei, Zhang Ying, Han YuanPing, Yu Hao, Chen Yu, Liu Mei, Duan ZhongPing. ShRNA targeted to rat Smad3 decreases the profibrosis role of TGFβ1 in HSC-T6 cells[J]. Journal of Clinical Hepatology, 2012, 28(4): 289-295. |
[7] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[8] | Li YaPing, Dang ShuangSuo, Zhai Song, Jia XiaoLi, Wang Yuan, Wang XiuFang, Wang WenJun, Li Mei. Immunohistochemical expression of NF-κB, α-SMA and TGFβ1 in experimental hepatic injury rats[J]. Journal of Clinical Hepatology, 2011, 27(11): 1207-1210. |
[9] | Li Jin, Jiang MiaoNa, Jia YuJie. Effect of Ganfukang on JAK2 and STAT3 expression in rats with liver fibrosis[J]. Journal of Clinical Hepatology, 2010, 26(5): 527-530. |
[10] | Jiang Ying, A YiTuLa. Expression of TGFβ1、TIMP1 in liver cirrhosis and pathological significance[J]. Journal of Clinical Hepatology, 2009, 25(1): 39-41. |
[12] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[13] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
[14] | Wang Yu, Gao Yi, Jiang XiaoQing. Stromelysin-1 proenzyme expression in the processe of experimental liver fibrosis.[J]. Journal of Clinical Hepatology, 2003, 19(6): 356-357. |
[15] | Sun YuanJie, Zhao Ming, Liu FuXu, Yang Li, Zhang Ying, Liu ZhiZhong, Yan BoQun, Xu Tao. Significance of serum laminin and type Ⅳ collagen content change between liver benign lesions and malignant tumor[J]. Journal of Clinical Hepatology, 2003, 19(4): 252-253. |
[16] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
[17] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
[18] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |